96 well pin replicators (Scinomix Inc)
90
Structured Review
Scinomix Inc
96 well pin replicators
96 Well Pin Replicators, supplied by Scinomix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/96-pin+replicator/96+well+pin+replicators/bio_rxiv__2024__12__11__627965-157-26-25
Average 90 stars, based on 1 article reviews
96 Well Pin Replicators, supplied by Scinomix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/96-pin+replicator/96+well+pin+replicators/bio_rxiv__2024__12__11__627965-157-26-25
Average 90 stars, based on 1 article reviews
96 well pin replicators - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Sterility:Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: All drug susceptibility assay wells were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Article Title: Inhibition and diagnostics of emerging tetracycline resistance enzymes Article Snippet: A sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: All drug-susceptibility assay wells were inoculated with ~1 μl of mid-log-phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 colony-forming units (c.f.u.) per ml) using a sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline-resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: On day 0, all drug susceptibility assay wells from plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 c.f.u./ml) using a sterile Article Title: Directed evolution of biofuel-responsive biosensors for automated optimization of branched-chain alcohol biosynthesis. Article Snippet: Transfer of master cultures into screening cultures was achieved using a Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: On day zero, all drug susceptibility assay wells from Plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Expressing:Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: All drug susceptibility assay wells were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Article Title: Inhibition and diagnostics of emerging tetracycline resistance enzymes Article Snippet: A sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: All drug-susceptibility assay wells were inoculated with ~1 μl of mid-log-phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 colony-forming units (c.f.u.) per ml) using a sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline-resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: On day 0, all drug susceptibility assay wells from plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 c.f.u./ml) using a sterile Article Title: Directed evolution of biofuel-responsive biosensors for automated optimization of branched-chain alcohol biosynthesis. Article Snippet: Transfer of master cultures into screening cultures was achieved using a Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: On day zero, all drug susceptibility assay wells from Plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Drug Susceptibility Assay:Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: All drug susceptibility assay wells were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Article Title: Inhibition and diagnostics of emerging tetracycline resistance enzymes Article Snippet: A sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: All drug-susceptibility assay wells were inoculated with ~1 μl of mid-log-phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 colony-forming units (c.f.u.) per ml) using a sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline-resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: On day 0, all drug susceptibility assay wells from plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 c.f.u./ml) using a sterile Article Title: Directed evolution of biofuel-responsive biosensors for automated optimization of branched-chain alcohol biosynthesis. Article Snippet: Transfer of master cultures into screening cultures was achieved using a Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: On day zero, all drug susceptibility assay wells from Plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Membrane:Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: All drug susceptibility assay wells were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile Article Title: Inhibition and diagnostics of emerging tetracycline resistance enzymes Article Snippet: A sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: All drug-susceptibility assay wells were inoculated with ~1 μl of mid-log-phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 colony-forming units (c.f.u.) per ml) using a sterile Article Title: Plasticity, dynamics, and inhibition of emerging tetracycline-resistance enzymes Article Snippet: A sterile 96-pin replicator ( Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Article Snippet: On day 0, all drug susceptibility assay wells from plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 108 c.f.u./ml) using a sterile Article Title: Directed evolution of biofuel-responsive biosensors for automated optimization of branched-chain alcohol biosynthesis. Article Snippet: Transfer of master cultures into screening cultures was achieved using a Article Title: Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA Article Snippet: On day zero, all drug susceptibility assay wells from Plate 1 were inoculated with ~1 μl of mid-log phase MRSA N315 bacterial culture at 0.5 McFarland standard (~2 × 10 8 CFU/ml) using a sterile |